Opinion: STAT+: The necessary roughness of 2023 has set up a very promising 2024 for biotech jobs
What a week — this year’s might have been the busiest JPM I’ve ever had….
Category: JPM 2024
Pumping breastmilk in bathrooms is a common, albeit unspoken, practice at health care conferences
Even though Erin Booth was not thrilled about having to travel to Philadelphia for a…
STAT+: At health care’s biggest investor conference, AI’s high hopes collided with skepticism
You didn’t need machine learning to make one prediction about the year’s biggest conference for…
The state of Medicare Advantage, in one chart
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
STAT+: Nonprofit health systems plug their strong cash reserves at JPM — a very different pitch than they make elsewhere
SAN FRANCISCO — Hospital leaders spent a good chunk of their stage time at the…
STAT Virtual Event | 2024 JPM Recap, Live!
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
Opinion: Pumping milk at JPM was a nightmare. It’s part of a bigger problem in the industry
Since having a baby 10 months ago, I’ve learned many things. Chief among them: Pumping…
STAT+: A biotech reporter’s notebook: Sunshine rains down on San Francisco
SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan…
STAT+: At JPM, Verve details plot to take genome editing mainstream
SAN FRANCISCO — The promise of genome editing has given rise to potentially curative medicines…
STAT+: FDA’s Peter Marks seems inclined to grant full approval to Sarepta’s Duchenne gene therapy
SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies,…
STAT+: Nvidia says a biological revolution is happening now. But is it?
SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway….
STAT+: JPM 2024: FogPharma’s new CEO, Mathai Mamman, unveils ‘contrarian’ plan in oncology
SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai…
STAT+: Mayo Clinic partners with supercomputing startup Cerebras to build custom AI tools
SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first…
STAT+: Hospitals try a new pitch to investors: other ways of making money
SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of…
This is the TLDR of JPM Day 1
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
STAT+: CVS Health sees Medicare Advantage patients seek more care, eating into profits
Medicare Advantage members continue to go to the doctor and get health care procedures a…
STAT+: Walgreens isn’t acquiring anytime soon, per CEO
Between Walgreens’ earnings call last week and its J.P. Morgan Healthcare Conference presentation on Monday,…
STAT+: At JPM, biotech’s most prolific dealmaker sees a rosy 2024 for acquisitions
SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong…
STAT+: At JPM, Bristol’s new CEO appeals to history to try to soothe investors’ nerves
SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two…
No pain data yet from Vertex, and sky high deal expectations at JPM 2024
Want to stay on top of the science and politics driving biotech today? Sign up to…
STAT+: Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM
New artificial intelligence technologies made headlines last year for their ability to do everything from…
STAT+: What to expect from hospitals and health insurers at this year’s JPM Healthcare Conference
Nonprofit hospitals often get overshadowed at the J.P. Morgan Healthcare Conference, the health care industry’s…
At JPM, how much health policy talk should we expect?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Burning questions for the 2024 JPM Healthcare Conference
The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and…
STAT+: Here’s who’s profiting the most in health care
For all the flack they get, the country’s four biggest pharmacy benefit managers reported a…